| Value | Category | Cases | |
|---|---|---|---|
| 1 | Oral administration | 35 |
71.4%
|
| 2 | Intravenous injection | 0 |
0%
|
| 3 | Topical Application | 0 |
0%
|
| 4 | Intramuscular injection | 14 |
28.6%
|
| 5 | Per Vagina | 0 |
0%
|
| Sysmiss | 3550 |